93
MOY, S. S.; NADLER, J.J.; YOUNG, N. B.; PEREZ, A.; HOLLOWAY, L. P.; BARBARO,
R. P. BARBARO, J.R.; WILSON, L.M.; THREADGILL, D.W.; LAUDER, J. M.;
MAGNUSON, T. R.; CRAWLEY, J. N. Mouse behavioral tasks relevant to autism:
phenotypes of 10 inbread strains. Behavioral Brain Research, v.176, p. 4-20, 2007.
MYERS, D.G. Introdução à psicologia geral. Rio de Janeiro:LTC,1999, p.171-187.
NIKOLOV, R.; JONKER, J.; SCAHILL, L. Autistic disorder: current
psychopharmacological treatments and areas of interest for future developments.
Revista Brasileira de Psiquiatria, v.28, p.S39-46, 2006. suplemento I.
PAPAZIAN, O.; ALFONSO, I.; LUZONDO, R.J. Transtornos de las funciones ejecutivas.
Revista de Neurologia, v.42, p. S45-50, 2006. suplemento I.
PENNINGTON, B.F.; OZZONOFF, S. Executive functions and developmental
psychology. Journal of Child Psychol Psyquiatry, v.37, p.51-87, 1996.
PIVEN J e col.AN MRI study of brain size in autism. American Journal of Psychiatry,
v.15, n.28, p. 1145- 1149.
POLLEUX, F.; LAUDER, J.M. Toward a developmental neurobiology of autism. Mental
Retardation and Developmental Disabilities Research Reviews, v.10, p. 303-317,
2004.
RIDDERINKHOF, R. K, e col. Neurocognitive mechanisms of cognitive control: The role
of prefrontal córtex in action selecion, response, inhibition, performance monitoring, and
reward-based learning. Brain and Cognition, v. 56, p.129-140, 2004.
RODIER, P.M. e col., Embryological origin for autism: developmental anomalies of the
cranial nerve motor nuclei. The Journal Of Comparative Neurology, v. 370, p. 247-
261, 1996.
SADAMATSU, M.; KANAI, H.; XU, X.; LIU, Y.; KATO, N. Review of animal models for
autism: implication of thyroid. Congenital Anomalies, v. 46, p. 1-9, 2006.
SCHNEIDER, T.; TURCZAK, J.; PRZEWTOCKI, R. Environmental enrichment reverses
behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic
approach in autism. Neuropsychopharmacology, v.31, p.36-46, 2006.